Author

Isabel Pérez-Martínez

ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY
ACCELERATED OR ESCALATED INDUCTION REGIMENS OF INFLIXIMAB FOR STEROID-REFRACTORY ACUTE SEVERE ULCERATIVE COLITIS IN CLINICAL PRACTICE: DATA FORM THE ENEIDA REGISTRY

Isabel Pérez-Martínez  et al.

VARICELLA ZOSTER VIRUS ENCEPHALITIS: A POTENTIALLY SERIOUS COMPLICATION DURING TREATMENT WITH VEDOLIZUMAB
VARICELLA ZOSTER VIRUS ENCEPHALITIS: A POTENTIALLY SERIOUS COMPLICATION DURING TREATMENT WITH VEDOLIZUMAB

Isabel Pérez-Martínez  et al.

EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF SWALLOWED TOPICAL CORTICOSTEROIDS FOR EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Isabel Pérez-Martínez  et al.

EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF FLUTICASONE AND BUDESONIDE FORMULATIONS TO INDUCE AND MAINTAIN REMISSION OF EOSINOPHILIC ESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Isabel Pérez-Martínez  et al.

PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY
PROTON PUMP INHIBITOR THERAPY REVERSES FIBROTIC ENDOSCOPIC FEATURES IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOE CONNECT REGISTRY

Isabel Pérez-Martínez  et al.

SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES
SPORADIC VERSUS FAMILIAL PRESENTATION OF EOSINOPHILIC ESOPHAGITIS: A COMPARATIVE ANALYSIS OF THE EOE CONNECT REGISTRY ON DEMOGRAPHIC, CLINICAL CHARACTERISTICS AND EARLY-LIFE EXPOSURES

Isabel Pérez-Martínez  et al.

EFFICACY OF PROTON-PUMP INHIBITOR THERAPY FOR EOSINOPHILIC OESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY
EFFICACY OF PROTON-PUMP INHIBITOR THERAPY FOR EOSINOPHILIC OESOPHAGITIS IN REAL-WORLD PRACTICE: RESULTS FROM THE EOE CONNECT REGISTRY

Isabel Pérez-Martínez  et al.

THE INFLUENCE OF PREOPERATIVE MEDICATIONS IN SURGICAL COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER STUDY OF GETECCU
THE INFLUENCE OF PREOPERATIVE MEDICATIONS IN SURGICAL COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE IN SPAIN: A MULTICENTER STUDY OF GETECCU

Isabel Pérez-Martínez  et al.

LIVE VACCINES IN CHILDREN EXPOSED TO BIOLOGICAL AGENTS FOR IBD IN UTERO AND/OR DURING BREASTFEEDING: ARE THEY SAFE? RESULTS FROM THE DUMBO REGISTRY OF GETECCU
LIVE VACCINES IN CHILDREN EXPOSED TO BIOLOGICAL AGENTS FOR IBD IN UTERO AND/OR DURING BREASTFEEDING: ARE THEY SAFE? RESULTS FROM THE DUMBO REGISTRY OF GETECCU

Isabel Pérez-Martínez  et al.

LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
LONG-TERM EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Isabel Pérez-Martínez  et al.

DURABILITY AND SAFETY OF UPADACITINIB IN CROHN’S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: PRELIMINARY RESULTS FROM A SPANISH NATIONWIDE STUDY
DURABILITY AND SAFETY OF UPADACITINIB IN CROHN’S DISEASE AND ULCERATIVE COLITIS IN REAL LIFE: PRELIMINARY RESULTS FROM A SPANISH NATIONWIDE STUDY

Isabel Pérez-Martínez  et al.

HIV INFECTION IS ASSOCIATED WITH A LESS AGGRESSIVE PHENOTYPE OF INFLAMMATORY BOWEL DISEASE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY
HIV INFECTION IS ASSOCIATED WITH A LESS AGGRESSIVE PHENOTYPE OF INFLAMMATORY BOWEL DISEASE. A MULTICENTER STUDY BASED ON THE ENEIDA REGISTRY

Isabel Pérez-Martínez  et al.

RISK FACTORS AND LONG-TERM OUTCOMES ASSOCIATED WITH IMMUNOSUPPRESSION IN PATIENTS WITH ULCERATIVE PROCTITIS: RESULTS FROM THE ENEIDA REGISTRY
RISK FACTORS AND LONG-TERM OUTCOMES ASSOCIATED WITH IMMUNOSUPPRESSION IN PATIENTS WITH ULCERATIVE PROCTITIS: RESULTS FROM THE ENEIDA REGISTRY

Isabel Pérez-Martínez  et al.

PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU
PERFORMANCE OF SCREENING STRATEGIES FOR LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY OF GETECCU

Isabel Pérez-Martínez  et al.

DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE
DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE

Isabel Pérez-Martínez  et al.

DIFFERENCES BETWEEN PAEDIATRIC AND ADULT EOSINOPHILIC ESOPHAGITIS AT DIAGNOSIS: RESULTS FROM THE EOE CONNECT REGISTRY
DIFFERENCES BETWEEN PAEDIATRIC AND ADULT EOSINOPHILIC ESOPHAGITIS AT DIAGNOSIS: RESULTS FROM THE EOE CONNECT REGISTRY

Isabel Pérez-Martínez  et al.

SAFETY OF INFLAMMATORY BOWEL DISEASE DRUGS DURING PREGNANCY AND BREASTFEEDING: MOTHERS AND BABIES’ OUTCOMES (DUMBO REGISTRY)
SAFETY OF INFLAMMATORY BOWEL DISEASE DRUGS DURING PREGNANCY AND BREASTFEEDING: MOTHERS AND BABIES’ OUTCOMES (DUMBO REGISTRY)

Isabel Pérez-Martínez  et al.

IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU
IMPACT OF BIOLOGICAL AGENTS ON POSTOPERATIVE COMPLICATIONS IN INFLAMMATORY BOWEL DISEASE: A MULTICENTRE STUDY OF GETECCU

Isabel Pérez-Martínez  et al.

COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY
COMORBIDITIES AND EPIDEMIOLOGICAL RISK FACTOR BUT NOT IMMUNOSUPPRESSIVE THERAPIES INCREASE THE RISK OF COVID-19 IN INFLAMMATORY BOWEL DISEASE (IBD): AN ENEIDA-BASED, CASE-CONTROL STUDY

Isabel Pérez-Martínez  et al.

INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU
INFLAMMATORY BOWEL DISEASE (IBD) AND IMMUNOSUPPRESSION DO NOT WORSEN THE PROGNOSIS OF COVID-19. RESULTS FROM THE ENEIDA PROJECT OF GETECCU

Isabel Pérez-Martínez  et al.

Item 1 - 20 / 20
1